Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Hair loss in older men is linked to higher rates of diabetes and high blood pressure.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Some men with early hair loss may have a condition similar to PCOS in women.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Normal levels for certain hormones in Chinese women of reproductive age were identified.